Body cites uncertainty over manufacturer’s data.
NICE rejected Ibrance in initial decision in February.
Gaining access to ultra-orphan drugs could become much more difficult.
Drug will also be available to children via Cancer Drugs Fund.
NHS funding at heart of pharma’s election manifesto.
Healios endorsed for improving access to CBT for young people with anxiety.